Search company, investor...

Founded Year

1992

Stage

Acq - P2P | Acquired

Total Raised

$51.16M

About Verenium

Verenium, formerly Diversa, focuses on the development and the commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as higher performance specialty enzymes for applications within the biofuels, industrial, and animal nutrition and health markets.

Headquarters Location

San Diego, California,

United States

Loading...

Loading...

Verenium Patents

Verenium has filed 60 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/12/2013

7/10/2018

EC 3.2.1, Protein domains, Protein families, Molecular biology, Genetics

Grant

Application Date

3/12/2013

Grant Date

7/10/2018

Title

Related Topics

EC 3.2.1, Protein domains, Protein families, Molecular biology, Genetics

Status

Grant

Latest Verenium News

Amylase Testing Market Segmentation, Emerging Demands and Global Forecast 2029

Sep 14, 2021

Amylase Testing Market Segmentation, Emerging Demands and Global Forecast 2029 Amylase Testing  market players – Amano Enzyme, Novozymes, DSM, Verenium, AB Enzymes, Dupont Danisco, Specialty Enzymes & Biotechnologies, Suzhou Sino Enzymes, Leveking, among others represent the global Amylase Testing market. The market study depicts an extensive analysis of all the players running in the Amylase Testing market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Amylase Testing market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global Amylase Testing market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the Amylase Testing market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Request For Table Of Content @  https://www.futuremarketinsights.com/toc/rep-gb-10976 Report Highlights: Any Queries, Contact Us @  https://www.futuremarketinsights.com/askus/rep-gb-10976 Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global Amylase Testing market? What are the drivers and challenges affecting the Amylase Testing market demand? What are the recent technological advancement in the Amylase Testing market? What are key trends and opportunities that will prevail the revenue growth of Amylase Testing market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the Amylase Testing market? Reasons to Buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the Amylase Testing market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact

Verenium Frequently Asked Questions (FAQ)

  • When was Verenium founded?

    Verenium was founded in 1992.

  • Where is Verenium's headquarters?

    Verenium's headquarters is located at San Diego.

  • What is Verenium's latest funding round?

    Verenium's latest funding round is Acq - P2P.

  • How much did Verenium raise?

    Verenium raised a total of $51.16M.

  • Who are the investors of Verenium?

    Investors of Verenium include BASF, Rho Ventures, Whiz Partners, GoldPoint Partners, Benefit Capital Companies and 7 more.

  • Who are Verenium's competitors?

    Competitors of Verenium include CleanCut Technologies and 8 more.

Loading...

Compare Verenium to Competitors

S
SaskAlta Base Oil

SaskAlta Base Oil is engaged in the re-refining of used lube oils

P
PetroBeam

PetroBeam is an energy technology company and is a developer of electron beam processing techniques to upgrade heavy petroleum feedstocks. The Company is migrating a well established industrial process to the midstream and downstream sectors of the petroleum industry. The PetroBeam technology is based on the fundamentals of electron beam ("e-beam") processing, which is exposing a material to a directed shower of electrons generated from an accelerator similar to those used to treat cancer patients.

A
American Energy Independence

American Energy Independence refines spent vegetable oil into fuel and distributes multi-fuel burners

Avista Logo
Avista

Avista (NYSE:AVA) is an energy company involved in the production, transmission and distribution of energy as well as other energy-related businesses.

C
CleanCut Technologies

CleanCut Technologies is a one-stop source for medical device packaging design and manufacturing. The company offers a complete product packaging portfolio to safely and securely retain and protect devices.

A
Atlantic Industrial

Atlantic Industrial aims to provide industrial services to refineries, power plants, and pulp and paper mills.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.